Halozyme Therapeutics | Bienes



Assets Cambio Fecha
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amarin USD 750.62M 49.24M 2024-09
Amgen USD 89.37B 2.47B 2025-03
Baxter International USD 25.78B 894M 2024-12
Cytokinetics USD 1.26B 137.62M 2025-03
DBV Technologies USD 65.7M 27.36M 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
Indivior 1.38B 56M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
MannKind USD 393.84M 70.36M 2024-12
Pfizer USD 208.03B 5.37B 2025-03
United Therapeutics USD 7.74B 379.9M 2025-03



Halozyme Therapeutics Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.